UroGen Pharma
URGN
URGN
115 hedge funds and large institutions have $641M invested in UroGen Pharma in 2024 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 55 increasing their positions, 20 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
13.33% more ownership
Funds ownership: 79.61% → 92.94% (+13%)
3% more funds holding
Funds holding: 112 → 115 (+3)
25% less call options, than puts
Call options by funds: $3.18M | Put options by funds: $4.24M
Holders
115
Holding in Top 10
3
Calls
$3.18M
Puts
$4.24M
Top Buyers
| 1 | +$33.6M | |
| 2 | +$27.7M | |
| 3 | +$24.3M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$22.4M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$22.1M |
Top Sellers
| 1 | -$4.32M | |
| 2 | -$4.31M | |
| 3 | -$3.52M | |
| 4 |
AA
AlphaCentric Advisors
San Juan,
Puerto Rico
|
-$2.16M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$1.51M |